Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
97
BTSG Quote, Financials, Valuation and Earnings
Last price:
$39.52
Seasonality move
:
6.75%
Day range:
$38.95 - $41.03
52-week range:
$15.26 - $41.03
Dividend yield:
0%
P/E ratio:
67.89x
P/S ratio:
0.71x
P/B ratio:
4.03x
Volume:
2.3M
Avg. volume:
1.9M
1-year change:
138.53%
Market cap:
$7.3B
Revenue:
$11.3B
EPS (TTM):
$0.60
Analysts' Opinion
-
Consensus RatingBrightSpring Health Services, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $42.20, BrightSpring Health Services, Inc. has an estimated upside of 3.76% from its current price of $40.67.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $38.00 representing 6.57% downside risk from its current price of $40.67.
Fair Value
-
According to the consensus of 14 analysts, BrightSpring Health Services, Inc. has 3.76% upside to fair value with a price target of $42.20 per share.
BTSG vs. S&P 500
-
Over the past 5 trading days, BrightSpring Health Services, Inc. has overperformed the S&P 500 by 5.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
BrightSpring Health Services, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BrightSpring Health Services, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter BrightSpring Health Services, Inc. reported revenues of $3.3B.
Earnings Growth
-
BrightSpring Health Services, Inc. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter BrightSpring Health Services, Inc. reported earnings per share of $0.26.
Enterprise value:
9.9B
EV / Invested capital:
--
Price / LTM sales:
0.71x
EV / EBIT:
27.26x
EV / Revenue:
0.80x
PEG ratio (5yr expected):
-0.18x
EV / Free cash flow:
31.00x
Price / Operating cash flow:
27.46x
Enterprise value / EBITDA:
18.24x
Gross Profit (TTM):
$1.5B
Return On Assets:
1.18%
Net Income Margin (TTM):
0.57%
Return On Equity:
4.14%
Return On Invested Capital:
1.57%
Operating Margin:
3.17%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $8.4B | $9.7B | $12.4B | $2.6B | $3.3B | |
| Gross Profit | $1.4B | $1.3B | $1.5B | $323.1M | $392M | |
| Operating Income | $190.6M | $228.2M | $363M | $62.7M | $105.5M | |
| EBITDA | $395.2M | $428.8M | $542.6M | $113.3M | $146.3M | |
| Diluted EPS | -$1.19 | -$0.25 | $0.60 | -$0.04 | $0.26 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | -- | $1.4B | $1.7B | $2.8B | |
| Total Assets | $5.4B | -- | $5.5B | $5.8B | $6B | |
| Current Liabilities | $884.4M | -- | $1B | $1.3B | $1.5B | |
| Total Liabilities | $4.6B | -- | $4.8B | $4.2B | $4.2B | |
| Total Equity | $796.5M | -- | $659.2M | $1.6B | $1.8B | |
| Total Debt | $3.6B | -- | $3.7B | $2.9B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $95.6M | $392.4M | $70.4M | $107.9M | |
| Cash From Investing | -- | -$143.1M | -$92.1M | -$37.8M | -$23.8M | |
| Cash From Financing | -- | $71.8M | -$195M | -$21.6M | -$13.1M | |
| Free Cash Flow | -- | $13.1M | $319.3M | $50.4M | $92.2M | |
BTSG
Sector
Market Cap
$7.3B
$28.5M
Price % of 52-Week High
99.12%
51.36%
Dividend Yield
0%
0%
Shareholder Yield
0.53%
-1.55%
1-Year Price Total Return
138.53%
-20%
Beta (5-Year)
--
0.497
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$38.27
200-day SMA
Buy
Level
$25.77
Bollinger Bands (100)
Buy
Level
26.18 - 35.68
Chaikin Money Flow
Buy
Level
78.8M
20-day SMA
Buy
Level
$36.98
Relative Strength Index (RSI14)
Buy
Level
75.50
ADX Line
Buy
Level
28.45
Williams %R
Sell
Level
-5.9801
50-day SMA
Buy
Level
$35.02
MACD (12, 26)
Buy
Level
1.26
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
143.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4113)
Sell
CA Score
(Annual)
Level (-0.9376)
Sell
Beneish M-Score
(Annual)
Level (-2.2053)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (4.6789)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Stock Forecast FAQ
In the current month, BTSG has received 14 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BTSG average analyst price target in the past 3 months is $42.20.
-
Where Will BrightSpring Health Services, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that BrightSpring Health Services, Inc. share price will rise to $42.20 per share over the next 12 months.
-
What Do Analysts Say About BrightSpring Health Services, Inc.?
Analysts are divided on their view about BrightSpring Health Services, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BrightSpring Health Services, Inc. is a Sell and believe this share price will drop from its current level to $38.00.
-
What Is BrightSpring Health Services, Inc.'s Price Target?
The price target for BrightSpring Health Services, Inc. over the next 1-year time period is forecast to be $42.20 according to 14 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BTSG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BrightSpring Health Services, Inc. is a Buy. 14 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BTSG?
You can purchase shares of BrightSpring Health Services, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BrightSpring Health Services, Inc. shares.
-
What Is The BrightSpring Health Services, Inc. Share Price Today?
BrightSpring Health Services, Inc. was last trading at $39.52 per share. This represents the most recent stock quote for BrightSpring Health Services, Inc.. Yesterday, BrightSpring Health Services, Inc. closed at $40.67 per share.
-
How To Buy BrightSpring Health Services, Inc. Stock Online?
In order to purchase BrightSpring Health Services, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BTSG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BTSG
Sector
P/E ratio
67.89x
24.20x
PEG ratio
-0.18x
-0.01x
P/B ratio
4.03x
1.84x
Price / LTM sales
0.71x
1.60x
Growth Metrics
BTSG
Sector
Revenue growth
28.17%
4.62%
Earnings growth
717.35%
10.88%
Revenue (5-year growth)
20.01%
6.45%
Earnings forecast
$0.34
-$0.18
Profitability
BTSG
Sector
Profitability FY 2024
$1.6B
$3.6M
Return on invested capital
1.57%
-32.02%
Return on assets
1.18%
-28.31%
Return on equity
4.14%
-38%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Jan
27
Balance Sheet
BTSG
Sector
Total cash
$140.3M
$26.1M
Short term investments
--
$25.7M
Total assets
$6.2B
$76.6M
Long term debt
$2.7B
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
RGC alert for Jan 7
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 7
Western Digital Corp. [WDC] is down 8.88% over the past day.
Buy
75
DRUG alert for Jan 7
Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
